Publications by authors named "Mark A Turner"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

14

Total Likes

14

Extended Reach

21,329

Social Features

14
C
Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children.
Katharine Cheng, Fenna Mahler, Irja Lutsar, Begonya Nafria Escalera, Stefanie Breitenstein, Gilles Vassal, Joana Claverol, Nuria Noel Palacio, Ron Portman, Gavin Pope

Clin Transl Sci· March 2023

Videos about Article: user

1 13

View All Article and Social Media Activity
T
The future of neonatology.
Neena Modi, Nicola J Robertson, Mark Hanson, Paolo De Coppi, Allyah Abbas-Hanif, Mark A Turner

Arch Dis Child Fetal Neonatal Ed· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rapid time-resolved host gene expression signature predicts responses to antibiotic treatment in neonatal bacterial sepsis.
Edward C Parkinson, W John Watkins, Sarah Edkins, James E McLaren, Michelle N Clements, Mark A Turner

Sci Transl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Multi-Omics Approach Unveils Strong Immune Activation in the First Ten Days of Life in Extremely Preterm Infants.
Laura Burgess, Eva Caamaño Gutiérrez, Brian F Flanagan, Duncan Alexander Sylvestre, Carolyn M Slupsky, Mark A Turner

Metabolites· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study.
Evangelos Christou, Nikolina Lalagianni, Sheila M McSweeney, Chantal Cotter, Chuin Ying Ung, Mark A Turner

Br J Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience and lessons learned relating to investigational product supply in the design and delivery of a paediatric investigator-initiated clinical trial.
Mandy Wan, Mark A Turner, Gilles Cambonie, Ruth Kemper, Naouel Bouafia

Contemp Clin Trials Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consideration for Assessing Data/Models/Tools Expiration Supporting Drug Development and Clinical Decision Making.
Jeffrey S Barrett, Mark A Turner

Ther Innov Regul Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing and streamlining clinical trial services to support pediatric drug development across 21 countries in Europe: insights from the conect4children (c4c) network.
Sabah Attar, Francisca P Figueiras, Carla Peacock, Hazel Wohlfahrt, Birgitta C P Hüsken, Mark A Turner

Front Med (Lausanne)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the rare disease paediatric clinical trial availabilities in Europe.
Eva Degraeuwe, Mark A Turner, Ricardo M Fernandes, Ann Raes, Johan Vande Walle

Front Pediatr· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Common sense is hard work" but benefits from persistent collaboration: Lessons learnt from the development of The Collaborative Network for European Clinical Trials for Children (c4c) to support the conduct of paediatric clinical trials of medicines.
Sabah Attar, Carla Peacock, Mandy Wan, Erin Halil, Chloe Bickerstaff, Mark A Turner

Contemp Clin Trials Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process.
Breanne Stewart, Pirkko Lepola, Gunter F Egger, Fahimeda Ali, Albert J Allen, Mark A Turner

Front Med (Lausanne)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plant nutrient concentrations inform white-tailed deer diet limitations.
Mark A Turner, Craig A Harper, Marcus A Lashley, Bronson K Strickland, Mark Q Wilber

J Environ Manage· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric-specific content in data standards for health.
Mark A Turner, Dipak Kalra, Ronald Cornet, Avril Palmeri, Anando Sen

Arch Dis Child· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process.
Breanne Stewart, Pirkko Lepola, Gunter F Egger, Fahimeda Ali, Albert J Allen, Mark A Turner

Front Med (Lausanne)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better Medicines for Children: Lessons Learnt and Share Learnings at the EFGCP Annual Paediatric Conferences.
Solange Corriol-Rohou, Sabine Ingeborg Fürst-Recktenwald, Elin-Haf Davies, Martine Dehlinger-Kremer, Mark A Turner

Ther Innov Regul Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The nature and functions of appearance-related comparisons in body dysmorphic disorder.
Mark A Turner, David Veale, Martin Anson

Scand J Psychol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Neonatal sepsis definitions from randomised clinical trials.
Rían Hayes, Jack Hartnett, Gergana Semova, Cian Murray, Katherine Murphy, Mark A Turner

Pediatr Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advocating for drug development in newborn infants.
Karel Allegaert, Souvik Mitra, Anne Smits, Mark A Turner

Early Hum Dev· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial.
Andrew Sharp, Christine Cornforth, Richard Jackson, Jane Harrold, Mark A Turner

BJOG· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partnership of I-ACT for children (US) and European pediatric clinical trial networks to facilitate pediatric clinical trials.
Eva Degraeuwe, Collin Hovinga, Annelies De Maré, Ricardo M Fernandes, Callie Heaton, Mark A Turner

Front Pediatr· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orphan and paediatric medical devices in Europe: recommendations to support their availability for on-label and off-label clinical indications.
Tom Melvin, Marc M Dooms, Berthold Koletzko, Mark A Turner, Damien Kenny

Expert Rev Med Devices· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the COVID-19 pandemic and the changing landscape of CF on the cASPerCF trial: a real-world experience.
Emily L D Chesshyre, Jacob D Bradbury, Heather Cook, Francesca Rocchi, Kit Roes, Mark A Turner

Trials· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonizing Quality Improvement Metrics Across Global Trial Networks to Advance Paediatric Clinical Trials Delivery.
Sabah Attar, Angie Price, Collin Hovinga, Breanne Stewart, Thierry Lacaze-Masmonteil, Mark A Turner

Ther Innov Regul Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preterm prelabour rupture of membranes before 23 weeks' gestation: prospective observational study.
Laura Goodfellow, Angharad Care, Ciara Curran, Devender Roberts, Mark A Turner

BMJ Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The neonatal adverse event severity scale: current status, a stakeholders' assessment, and future perspectives.
Karel Allegaert, Thomas Salaets, Kelly Wade, Mary A Short, Robert Ward, Mark A Turner

Front Pediatr· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis